COX6B1
Basic information
Region (hg38): 19:35648323-35658782
Previous symbols: [ "COX6B" ]
Links
Phenotypes
GenCC
Source:
- mitochondrial complex IV deficiency, nuclear type 7 (Strong), mode of inheritance: AR
- cytochrome-c oxidase deficiency disease (Supportive), mode of inheritance: AR
- mitochondrial complex IV deficiency, nuclear type 7 (Definitive), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex IV deficiency, nuclear type 7 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Musculoskeletal; Neurologic; Ophthalmologic | 18499082 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (40 variants)
- Mitochondrial_complex_IV_deficiency,_nuclear_type_7 (12 variants)
- Inborn_genetic_diseases (10 variants)
- Mitochondrial_complex_IV_deficiency,_nuclear_type_1 (6 variants)
- not_specified (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COX6B1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001863.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 10 | ||||
missense | 17 | 21 | ||||
nonsense | 0 | |||||
start loss | 1 | 1 | ||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 2 | 18 | 12 | 0 |
Highest pathogenic variant AF is 0.00000547264
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COX6B1 | protein_coding | protein_coding | ENST00000246554 | 3 | 10639 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.121 | 0.788 | 125746 | 0 | 2 | 125748 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.748 | 40 | 55.7 | 0.718 | 0.00000370 | 576 |
Missense in Polyphen | 4 | 13.266 | 0.30152 | 183 | ||
Synonymous | 0.756 | 16 | 20.3 | 0.787 | 0.00000142 | 140 |
Loss of Function | 1.34 | 2 | 5.35 | 0.374 | 2.30e-7 | 56 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000176 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Connects the two COX monomers into the physiological dimeric form. {ECO:0000250}.;
- Disease
- DISEASE: Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations, ranging from isolated myopathy to severe multisystem disease affecting several tissues and organs. Features include hypertrophic cardiomyopathy, hepatomegaly and liver dysfunction, hypotonia, muscle weakness, exercise intolerance, developmental delay, delayed motor development and mental retardation. Some affected individuals manifest a fatal hypertrophic cardiomyopathy resulting in neonatal death. A subset of patients manifest Leigh syndrome. {ECO:0000269|PubMed:18499082}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cardiac muscle contraction - Homo sapiens (human);Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Huntington,s disease - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Parkinson,s disease - Homo sapiens (human);Electron Transport Chain;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TP53 Regulates Metabolic Genes;Transcriptional Regulation by TP53;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.433
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.04
Haploinsufficiency Scores
- pHI
- 0.113
- hipred
- Y
- hipred_score
- 0.709
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.855
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Low | Medium |
Mouse Genome Informatics
- Gene name
- Cox6b1
- Phenotype
Gene ontology
- Biological process
- substantia nigra development;electron transport chain;proton transmembrane transport
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial intermembrane space;respiratory chain complex IV
- Molecular function
- cytochrome-c oxidase activity;protein binding